What is the significance of a urine microscopic lab result showing leukocyturia (elevated White Blood Cells (WBCs)) and hematuria (elevated Red Blood Cells (RBCs))?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Significance of Elevated Urine WBCs (>182) and RBCs (177) in Microscopic Analysis

Elevated urine WBCs (>182) and RBCs (177) strongly suggest a urinary tract infection with possible underlying urologic or renal pathology requiring further evaluation. 1

Diagnostic Implications

Urinary Tract Infection

  • WBC count >182/μL significantly exceeds the established cutoff of 13 WBCs/μL for detecting urinary tract infections, indicating active inflammation in the urinary tract 1
  • The combination of elevated WBCs and RBCs has a sensitivity of 99.8% and negative predictive value of 100% for urinary tract infection when using the algorithm of ≥85 bacteria/μL and ≥13 WBCs/μL 1
  • Pyuria (elevated WBCs) in conjunction with bacteriuria is the most common presentation of urinary tract infection 2

Potential for Urologic Pathology

  • Concurrent hematuria (elevated RBCs) and leukocyturia (elevated WBCs) may indicate:
    • Urinary tract infection with mucosal inflammation and bleeding
    • Urolithiasis (kidney stones) with secondary infection
    • Underlying urologic malignancy with superimposed infection
    • Glomerular disease with secondary infection 3

Clinical Approach

Immediate Assessment

  • Confirm findings with repeat urinalysis if clinically indicated 3
  • Obtain urine culture to identify causative organism and determine antibiotic sensitivities 4, 3
  • Complete additional laboratory workup including:
    • Complete blood count
    • Serum creatinine and BUN
    • Urinalysis with microscopic examination 3

Risk Stratification

  • Higher risk factors requiring more aggressive evaluation:
    • Age >60 years
    • Male gender
    • Smoking history
    • Gross hematuria (if present)
    • History of pelvic radiation
    • Occupational exposure to chemicals 3

Imaging and Further Evaluation

Imaging Recommendations

  • If infection is confirmed and responds to treatment, repeat urinalysis after treatment to ensure resolution 3
  • If hematuria persists after treatment of infection, further imaging is indicated:
    • CT Urography (92% sensitivity, 93% specificity) is preferred for detecting stones, malignancy, and structural abnormalities
    • MR Urography if contrast allergy or renal insufficiency exists
    • Renal ultrasound as an alternative, especially in younger patients 3

Specialist Referral

  • Urologic referral is indicated for:
    • Persistent hematuria after treatment of infection
    • Age >60 years with unexplained hematuria
    • Recurrent UTIs 3
  • Nephrology referral if glomerular disease is suspected (especially if proteinuria is also present) 3

Common Pitfalls to Avoid

  • Relying solely on dipstick results without microscopic confirmation - microscopic examination is essential for accurate diagnosis 3
  • Assuming anticoagulant therapy is the cause of hematuria without further evaluation 3
  • Failing to repeat urinalysis after treating a presumed cause can lead to overlooked significant renal disease 3
  • Inadequate evaluation of concurrent hematuria and leukocyturia, which may represent more serious underlying pathology 3
  • Collecting urine samples improperly (from extension tubing or collection bag in catheterized patients) can lead to false results 3

Follow-up Recommendations

  • If infection is confirmed and treated:
    • Repeat urinalysis 1-2 weeks after completing antibiotics to confirm resolution
    • If hematuria or leukocyturia persists, more comprehensive evaluation is needed 3
  • For patients with resolved infection but risk factors for malignancy:
    • Consider surveillance with repeat urinalysis at 6,12,24, and 36 months 3
  • For patients with persistent abnormalities despite treatment:
    • Consider cystoscopy and upper tract imaging 3

The presence of both significant leukocyturia and hematuria requires thorough evaluation as it may represent serious underlying pathology beyond simple urinary tract infection.

References

Research

[Urine diagnosis and leukocyturia].

MMW Fortschritte der Medizin, 2004

Guideline

Hematuria Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.